Breakthrough AI system may improve treatment of debilitating diseases
Join the Clinical Committee as a Co-Opted Member

Update from Ferring Pharmaceuticals regarding Desmopressin

18 Sept 2023

Ferring Pharmaceuticals have provided updated information regarding the future supply of DesmoSpray® nasal spray, Octim® nasal spray solution and DDAVP® (Desmopressin) intranasal solution

Ferring Pharmaceuticals will discontinue DDAVP Intranasal solution (Nasal Drops) 0.1mg/ml. Key information from the update:

  1. Desmopressin spray will be available next year once they've fixed their packaging and assembly
  2. Desmopressin nasal drops going to be discontinued
  3. Desmopressin tablets still available.


For more information, you can read the update in full.

Any questions please email [email protected]

Share this story

Top stories

New research identifies rare genes behind early menopause
13 Sept 2024

Night owls more likely to develop type 2 diabetes
12 Sept 2024

New weight loss pill outperforms Wegovy in early trials
12 Sept 2024

Virtual peer review – ensure your centre has an up to date review and get involved as a reviewer
06 Sept 2024

NICE guideline on adrenal insufficiency: identification and management
06 Sept 2024

Most read